Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 76

    1.

    Diagnostic and therapeutic challenges.

    Querques G, Noci ND, Aaberg T Jr, Rosenfeld PJ.

    Retina. 2009 Sep;29(8):1195-200. No abstract available. PMID: 19696705 [PubMed - in process]Related articles

    2.

    Comparison of intravitreal bevacizumab followed by ranibizumab for the treatment of neovascular age-related macular degeneration.

    Stepien KE, Rosenfeld PJ, Puliafito CA, Feuer W, Shi W, Al-Attar L, Dubovy SR, Murray TG, Davis JL, Lee WH, Schwartz SG, Smiddy WE, Berrocal AM, Flynn HW Jr.

    Retina. 2009 Sep;29(8):1067-73.PMID: 19696701 [PubMed - in process]Related articles

    3.

    Spectral domain optical coherence tomography characteristics of cuticular drusen.

    Leng T, Rosenfeld PJ, Gregori G, Puliafito CA, Punjabi OS.

    Retina. 2009 Jul-Aug;29(7):988-93.PMID: 19584657 [PubMed - indexed for MEDLINE]Related articles

    4.

    Safety and efficacy of intravitreal bevacizumab (avastin) for the management of branch and hemiretinal vein occlusion.

    Gregori NZ, Rattan GH, Rosenfeld PJ, Puliafito CA, Feuer W, Flynn HW Jr, Berrocal AM, Al-Attar L, Dubovy S, Smiddy WE, Schwartz SG, Lee WH, Murray TG.

    Retina. 2009 Jul-Aug;29(7):913-25.PMID: 19584649 [PubMed - indexed for MEDLINE]Related articles

    5.

    Long-term safety and efficacy of intravitreal bevacizumab (Avastin) for the management of central retinal vein occlusion.

    Gregori NZ, Gaitan J, Rosenfeld PJ, Puliafito CA, Feuer W, Flynn HW Jr, Berrocal AM, Al-Attar L, Dubovy S, Smiddy WE, Schwartz SG, Lee WH, Murray TG.

    Retina. 2008 Oct;28(9):1325-37.PMID: 19430392 [PubMed - indexed for MEDLINE]Related articles

    6.

    Antivascular endothelial growth factor therapy for neovascular age-related macular degeneration.

    Ciulla TA, Rosenfeld PJ.

    Curr Opin Ophthalmol. 2009 May;20(3):158-65. Review.PMID: 19417570 [PubMed - indexed for MEDLINE]Related articles

    7.

    Anti-vascular endothelial growth factor therapy for neovascular ocular diseases other than age-related macular degeneration.

    Ciulla TA, Rosenfeld PJ.

    Curr Opin Ophthalmol. 2009 May;20(3):166-74. Review.PMID: 19381089 [PubMed - indexed for MEDLINE]Related articles

    8.

    A variable-dosing regimen with intravitreal ranibizumab for neovascular age-related macular degeneration: year 2 of the PrONTO Study.

    Lalwani GA, Rosenfeld PJ, Fung AE, Dubovy SR, Michels S, Feuer W, Davis JL, Flynn HW Jr, Esquiabro M.

    Am J Ophthalmol. 2009 Jul;148(1):43-58.e1. Epub 2009 Apr 18.PMID: 19376495 [PubMed - indexed for MEDLINE]Related articles

    9.

    When is off-label drug use in the patient's best interest?

    Rosenfeld PJ, Goodman KW.

    Am J Ophthalmol. 2009 May;147(5):761-3. No abstract available. PMID: 19376327 [PubMed - indexed for MEDLINE]Related articles

    10.

    Spectral domain optical coherence tomographic imaging of geographic atrophy.

    Lujan BJ, Rosenfeld PJ, Gregori G, Wang F, Knighton RW, Feuer WJ, Puliafito CA.

    Ophthalmic Surg Lasers Imaging. 2009 Mar-Apr;40(2):96-101.PMID: 19320296 [PubMed - indexed for MEDLINE]Related articles

    11.

    Outcomes of treatment of neovascular glaucoma with intravitreal bevacizumab.

    Moraczewski AL, Lee RK, Palmberg PF, Rosenfeld PJ, Feuer WJ.

    Br J Ophthalmol. 2009 May;93(5):589-93. Epub 2008 Dec 15.PMID: 19074917 [PubMed - indexed for MEDLINE]Related articles

    12.

    Macular spectral-domain optical coherence tomography in patients with X linked retinoschisis.

    Gregori NZ, Berrocal AM, Gregori G, Murray TG, Knighton RW, Flynn HW Jr, Dubovy S, Puliafito CA, Rosenfeld PJ.

    Br J Ophthalmol. 2009 Mar;93(3):373-8. Epub 2008 Nov 19.PMID: 19019942 [PubMed - indexed for MEDLINE]Related articles

    13.

    Geometric deformable model driven by CoCRFs: application to optical coherence tomography.

    Tsechpenakis G, Lujan B, Martinez O, Gregori G, Rosenfeld PJ.

    Med Image Comput Comput Assist Interv Int Conf Med Image Comput Comput Assist Interv. 2008;11(Pt 1):883-91.PMID: 18979829 [PubMed - indexed for MEDLINE]Related articles

    14.

    Bevacizumab (avastin) therapy for idiopathic macular telangiectasia type II.

    Kovach JL, Rosenfeld PJ.

    Retina. 2009 Jan;29(1):27-32.PMID: 18936721 [PubMed - indexed for MEDLINE]Related articles

    15.

    [Therapeutic efficacy and safety of off-label use of Bevacizumab for the treatment of neovascular diseases of the eye]

    Sun XD, Xu WQ, Rosenfeld PJ.

    Zhonghua Yan Ke Za Zhi. 2008 Mar;44(3):281-4. Chinese. PMID: 18785551 [PubMed - in process]Related articles

    16.

    Comparison of 2.5 mg/kg and 5 mg/kg systemic bevacizumab in neovascular age-related macular degeneration: twenty-four week results of an uncontrolled, prospective cohort study.

    Geitzenauer W, Michels S, Prager F, Rosenfeld PJ, Kornek G, Vormittag L, Schmidt-Erfurth U.

    Retina. 2008 Nov-Dec;28(10):1375-86.PMID: 18784625 [PubMed - indexed for MEDLINE]Related articles

    17.

    Imaging serpiginous choroidopathy with spectral domain optical coherence tomography.

    Punjabi OS, Rich R, Davis JL, Gregori G, Flynn HW Jr, Lujan BJ, Rosenfeld PJ, Puliafito CA.

    Ophthalmic Surg Lasers Imaging. 2008 Jul-Aug;39(4 Suppl):S95-8.PMID: 18777879 [PubMed - indexed for MEDLINE]Related articles

    18.

    Calibration of fundus images using spectral domain optical coherence tomography.

    Lujan BJ, Wang F, Gregori G, Rosenfeld PJ, Knighton RW, Puliafito CA, Danis RP, Hubbard LD, Chang RT, Budenz DL, Seider MI, Knight O.

    Ophthalmic Surg Lasers Imaging. 2008 Jul-Aug;39(4 Suppl):S15-20.PMID: 18777875 [PubMed - indexed for MEDLINE]Related articles

    19.

    Retinal toxicity of commercially available intravitreal ketorolac in albino rabbits.

    Komarowska I, Heilweil G, Rosenfeld PJ, Perlman I, Loewenstein A.

    Retina. 2009 Jan;29(1):98-105.PMID: 18626418 [PubMed - indexed for MEDLINE]Related articles

    20.

    Predicted biological activity of intravitreal VEGF Trap.

    Stewart MW, Rosenfeld PJ.

    Br J Ophthalmol. 2008 May;92(5):667-8. Epub 2008 Mar 20.PMID: 18356264 [PubMed - indexed for MEDLINE]Related articles

    21.

    Verteporfin therapy of subfoveal occult choroidal neovascularization in AMD using delayed light application: one-year results of the VALIO Study.

    Rosenfeld PJ, Boyer DS, Bressler NM, Fish G, Grizzard WS, Hao Y, Hnik P, Hudson HL, Singerman L, Slakter JS; VALIO Study Group.

    Am J Ophthalmol. 2007 Dec;144(6):970-972.PMID: 18036873 [PubMed - indexed for MEDLINE]Related articles

    22.

    New treatments for age-related macular degeneration.

    Rosenfeld PJ.

    Lancet. 2007 Oct 27;370(9597):1479; author reply 1480. No abstract available. PMID: 17964340 [PubMed - indexed for MEDLINE]Related articles

    23.

    Medical consequences of stopping anticoagulant therapy before intraocular surgery or intravitreal injections.

    Charles S, Rosenfeld PJ, Gayer S.

    Retina. 2007 Sep;27(7):813-5. No abstract available. PMID: 17891002 [PubMed - indexed for MEDLINE]Related articles

    24.

    An optical coherence tomography-guided, variable dosing regimen with intravitreal ranibizumab (Lucentis) for neovascular age-related macular degeneration.

    Fung AE, Lalwani GA, Rosenfeld PJ, Dubovy SR, Michels S, Feuer WJ, Puliafito CA, Davis JL, Flynn HW Jr, Esquiabro M.

    Am J Ophthalmol. 2007 Apr;143(4):566-83.PMID: 17386270 [PubMed - indexed for MEDLINE]Related articles

    25.

    Intravitreal Avastin for choroidal neovascularisation in pathological myopia: the controversy continues.

    Rosenfeld PJ.

    Br J Ophthalmol. 2007 Feb;91(2):128-30. No abstract available. PMID: 17244654 [PubMed - indexed for MEDLINE]Related articles

    26.

    Antiangiogenic therapy in neovascular age-related macular degeneration.

    Lin RC, Rosenfeld PJ.

    Int Ophthalmol Clin. 2007 Winter;47(1):117-37. Review. No abstract available. PMID: 17237677 [PubMed - indexed for MEDLINE]Related articles

    27.

    Verteporfin therapy for CNV secondary to OHS.

    Saperstein DA, Rosenfeld PJ, Bressler NM, Rosa RH Jr, Sternberg P Jr, Aaberg TM Sr, Aaberg TM Jr, Weisberger A.

    Ophthalmology. 2006 Dec;113(12):2371.e1-3. No abstract available. PMID: 17157140 [PubMed - indexed for MEDLINE]Related articles

    28.

    One-year safety and efficacy of intravitreal triamcinolone acetonide for the management of macular edema secondary to central retinal vein occlusion.

    Gregori NZ, Rosenfeld PJ, Puliafito CA, Flynn HW Jr, Lee JE, Mavrofrides EC, Smiddy WE, Murray TG, Berrocal AM, Scott IU, Gregori G.

    Retina. 2006 Oct;26(8):889-95.PMID: 17031288 [PubMed - indexed for MEDLINE]Related articles

    29.

    Systemic bevacizumab (Avastin) therapy for neovascular age-related macular degeneration: twenty-four-week results of an uncontrolled open-label clinical study.

    Moshfeghi AA, Rosenfeld PJ, Puliafito CA, Michels S, Marcus EN, Lenchus JD, Venkatraman AS.

    Ophthalmology. 2006 Nov;113(11):2002.e1-12. Epub 2006 Oct 5.PMID: 17027972 [PubMed - indexed for MEDLINE]Related articles

    30.

    Ranibizumab for neovascular age-related macular degeneration.

    Rosenfeld PJ, Brown DM, Heier JS, Boyer DS, Kaiser PK, Chung CY, Kim RY; MARINA Study Group.

    N Engl J Med. 2006 Oct 5;355(14):1419-31.PMID: 17021318 [PubMed - indexed for MEDLINE]Related articlesFree article

    31.

    Ranibizumab: Phase III clinical trial results.

    Rosenfeld PJ, Rich RM, Lalwani GA.

    Ophthalmol Clin North Am. 2006 Sep;19(3):361-72. Review.PMID: 16935211 [PubMed - indexed for MEDLINE]Related articles

    32.

    The International Intravitreal Bevacizumab Safety Survey: using the internet to assess drug safety worldwide.

    Fung AE, Rosenfeld PJ, Reichel E.

    Br J Ophthalmol. 2006 Nov;90(11):1344-9. Epub 2006 Jul 19.PMID: 16854824 [PubMed - indexed for MEDLINE]Related articlesFree article

    33.

    Intravitreal avastin: the low cost alternative to lucentis?

    Rosenfeld PJ.

    Am J Ophthalmol. 2006 Jul;142(1):141-3. No abstract available. PMID: 16815262 [PubMed - indexed for MEDLINE]Related articles

    34.

    Promising new treatments for neovascular age-related macular degeneration.

    Michels S, Schmidt-Erfurth U, Rosenfeld PJ.

    Expert Opin Investig Drugs. 2006 Jul;15(7):779-93. Review.PMID: 16787141 [PubMed - indexed for MEDLINE]Related articles

    35.

    Short-term safety and efficacy of intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration.

    Rich RM, Rosenfeld PJ, Puliafito CA, Dubovy SR, Davis JL, Flynn HW Jr, Gonzalez S, Feuer WJ, Lin RC, Lalwani GA, Nguyen JK, Kumar G.

    Retina. 2006 May-Jun;26(5):495-511.PMID: 16770255 [PubMed - indexed for MEDLINE]Related articles

    36.

    Verteporfin photodynamic therapy of choroidal neovascularization secondary to ocular toxoplasmosis.

    Wirthlin R, Song A, Song J, Rosenfeld PJ.

    Arch Ophthalmol. 2006 May;124(5):741-3. No abstract available. PMID: 16682600 [PubMed - indexed for MEDLINE]Related articles

    37.

    Tolerability and efficacy of multiple escalating doses of ranibizumab (Lucentis) for neovascular age-related macular degeneration.

    Rosenfeld PJ, Heier JS, Hantsbarger G, Shams N.

    Ophthalmology. 2006 Apr;113(4):623.e1.PMID: 16581423 [PubMed - indexed for MEDLINE]Related articles

    38.

    Ranibizumab for treatment of neovascular age-related macular degeneration: a phase I/II multicenter, controlled, multidose study.

    Heier JS, Antoszyk AN, Pavan PR, Leff SR, Rosenfeld PJ, Ciulla TA, Dreyer RF, Gentile RC, Sy JP, Hantsbarger G, Shams N.

    Ophthalmology. 2006 Apr;113(4):633.e1-4. Epub 2006 Feb 14.PMID: 16483659 [PubMed - indexed for MEDLINE]Related articles

    39.

    Verteporfin therapy for subfoveal choroidal neovascularization in age-related macular degeneration: four-year results of an open-label extension of 2 randomized clinical trials: TAP Report No. 7.

    Bressler NM, Bressler SB, Haynes LA, Hao Y, Kaiser PK, Miller JW, Naor J, Potter MJ, Pournaras CJ, Reaves A, Rosenfeld PJ, Schmidt-Erfurth U, Slakter JS, Strong A, Vannier S.

    Arch Ophthalmol. 2005 Sep;123(9):1283-5. No abstract available. PMID: 16157822 [PubMed - indexed for MEDLINE]Related articles

    40.

    Optical coherence tomography findings after an intravitreal injection of bevacizumab (avastin) for macular edema from central retinal vein occlusion.

    Rosenfeld PJ, Fung AE, Puliafito CA.

    Ophthalmic Surg Lasers Imaging. 2005 Jul-Aug;36(4):336-9.PMID: 16156153 [PubMed - indexed for MEDLINE]Related articles

    41.

    Optical coherence tomography findings after an intravitreal injection of bevacizumab (avastin) for neovascular age-related macular degeneration.

    Rosenfeld PJ, Moshfeghi AA, Puliafito CA.

    Ophthalmic Surg Lasers Imaging. 2005 Jul-Aug;36(4):331-5.PMID: 16156152 [PubMed - indexed for MEDLINE]Related articles

    42.

    [Treatment of neovascular age-related macular degeneration with Ranibizumab/Lucentis]

    Michels S, Rosenfeld PJ.

    Klin Monbl Augenheilkd. 2005 Jun;222(6):480-4. Review. German. PMID: 15973626 [PubMed - indexed for MEDLINE]Related articles

    43.

    Systemic bevacizumab (Avastin) therapy for neovascular age-related macular degeneration twelve-week results of an uncontrolled open-label clinical study.

    Michels S, Rosenfeld PJ, Puliafito CA, Marcus EN, Venkatraman AS.

    Ophthalmology. 2005 Jun;112(6):1035-47.PMID: 15936441 [PubMed - indexed for MEDLINE]Related articles

    44.

    Maximum tolerated dose of a humanized anti-vascular endothelial growth factor antibody fragment for treating neovascular age-related macular degeneration.

    Rosenfeld PJ, Schwartz SD, Blumenkranz MS, Miller JW, Haller JA, Reimann JD, Greene WL, Shams N.

    Ophthalmology. 2005 Jun;112(6):1048-53.PMID: 15885778 [PubMed - indexed for MEDLINE]Related articles

    45.

    Verteporfin therapy of subfoveal minimally classic choroidal neovascularization in age-related macular degeneration: 2-year results of a randomized clinical trial.

    Azab M, Boyer DS, Bressler NM, Bressler SB, Cihelkova I, Hao Y, Immonen I, Lim JI, Menchini U, Naor J, Potter MJ, Reaves A, Rosenfeld PJ, Slakter JS, Soucek P, Strong HA, Wenkstern A, Su XY, Yang YC; Visudyne in Minimally Classic Choroidal Neovascularization Study Group.

    Arch Ophthalmol. 2005 Apr;123(4):448-57.PMID: 15824216 [PubMed - indexed for MEDLINE]Related articles

    46.

    Verteporfin in Photodynamic Therapy: report no. 5.

    Bandello F, Blinder K, Bressler NM, Brown AL, Miller JW, Potter MJ, Pournaras C, Reaves A, Rosenfeld PJ, Slakter JS, Soubrane G, Strong HA, Stur M; VIP Report No. 5 Writing Committee.

    Ophthalmology. 2004 Nov;111(11):2144. No abstract available. PMID: 15522385 [PubMed - indexed for MEDLINE]Related articles

    47.

    Retinal angiomatous proliferation: clinical characteristics and treatment options.

    Hunter MA, Dunbar MT, Rosenfeld PJ.

    Optometry. 2004 Sep;75(9):577-88.PMID: 15481226 [PubMed - indexed for MEDLINE]Related articles

    48.

    Photodynamic therapy with verteporfin in ocular histoplasmosis: uncontrolled, open-label 2-year study.

    Rosenfeld PJ, Saperstein DA, Bressler NM, Reaves TA, Sickenberg M, Rosa RH Jr, Sternberg P Jr, Aaberg TM Sr, Aaberg TM Jr; Verteporfin in Ocular Histoplasmosis Study Group.

    Ophthalmology. 2004 Sep;111(9):1725-33.PMID: 15350329 [PubMed - indexed for MEDLINE]Related articles

    49.

    Age-related maculopathy: a genomewide scan with continued evidence of susceptibility loci within the 1q31, 10q26, and 17q25 regions.

    Weeks DE, Conley YP, Tsai HJ, Mah TS, Schmidt S, Postel EA, Agarwal A, Haines JL, Pericak-Vance MA, Rosenfeld PJ, Paul TO, Eller AW, Morse LS, Dailey JP, Ferrell RE, Gorin MB.

    Am J Hum Genet. 2004 Aug;75(2):174-89. Epub 2004 May 27.PMID: 15168325 [PubMed - indexed for MEDLINE]Related articlesFree article

    50.

    Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: meta-analysis of 2-year safety results in three randomized clinical trials: Treatment Of Age-Related Macular Degeneration With Photodynamic Therapy and Verteporfin In Photodynamic Therapy Study Report no. 4.

    Azab M, Benchaboune M, Blinder KJ, Bressler NM, Bressler SB, Gragoudas ES, Fish GE, Hao Y, Haynes L, Lim JI, Menchini U, Miller JW, Mones J, Potter MJ, Reaves A, Rosenfeld PJ, Strong A, Su XY, Slakter JS, Schmidt-Erfurth U, Sorenson JA; Treatment of Age-Related Macular Degeneration with Photodynamic Therapy (TAP) Study Group; Verteporfin in Photodynamic Therapy (VIP) Study Group.

    Retina. 2004 Feb;24(1):1-12.PMID: 15076937 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...